WuXi Biologics and Aravive join forces on high-affinity bispecific antibodies

The collaboration will target cancer and fibrosis and use the WuXiBody Platform

picture of

Breaking News

Mission raises $15m and expands relationship with Pfizer

The new capital will support the development of Mission's deubiquitylating enzymes (DUB) platform, as well as growth of ...

Sigrid Therapeutics obtains US patent for silica-based biomaterial SiPore15 for the treatment and prevention of obesity

Mesoporous silica particles (MSP) are a type of ingestible synthetic amorphous silica particles that can be produced ...

CPhI plans 'Pharma Festival' digital experience to replace postponed worldwide event

Informa have agreed with key partners to adapt to a digital format in 2020, a large-scale digital exhibition that will ...

Identifying nitrosamines in pharmaceutical products

The TEA detector has long been an industry standard for nitrosamine analysis in food and beverages, which can also be ...

DuPont achieves Non-GMO Certification for SeaGel

DuPont Nutrition & Biosciences’ latest certification will allow manufacturers to add the iconic non-GMO Project ...

Respira Technologies pursues API partnerships for new nebuliser

US-based Respira has launched pharmaceutical-focused commercial development platform for RespiRx medical device platform

How to comply with FDA-imposed nitrosamine impurity testing

The detection of nitrosamine impurities in commercially available drugs has recently prompted the US FDA to issue ...

Rousselot introduces GMP-ready gelatin methacryloyl biomaterials

GelMA-oriented patent applications have been growing exponentially over the last 5 years, with many of these research ...

VistaGen and Nuformix agree to develop cocrystalline forms of AV-101

The drug for treatment of multiple CNS conditions will be reformed into a novel patentable form to potentially improve ...

Nitrosamines: Information for Marketing Authorisation Holders

Nitrosamine impurities have been in the regulatory spotlight since they were discovered in several blood pressure ...

Excipient innovation for enhanced patient compliance: part II

Formulation can be challenging, particularly when working with excipients such as sugar alcohols. However, a new line ...

The Lonza powder-in-capsule microdosing approach

Jeff Williamson and Ben Sahacic explain how microdosing offers a proven approach for biopharmaceutical companies to ...

Beximco Pharma introduces first generic remdesivir for COVID-19

Beximco Pharma is donating remdesivir (Bemsivir) to the Bangladesh Government for supply only to Government hospitals

BioMed X launches rapid antiviral response platform

BioMed X is striving to develop an arsenal of ultrafast new antiviral drug discovery, development and mass-m ...